jRCTs071190020招募中不适用
Efficacy and safety of triclabendazole for the treatment of fasciolosis (Egaten study)
未提供0 个研究点目标入组 50 人开始时间: 2019年8月30日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 50
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- No limit 至 No limit（—）
- 性别
- All
入选标准
- •Patients who are diagnosed as having fasciolosis
- •Patients who give written informed consent
- •Informed consent from proxies are obtained
排除标准
- •Patients who are allergic to Triclabendazole
- •Patients who are pregnant, or possibly pregnant
- •Patients who does not give written informed consent
- •Patients principal investigator judged inappropriate
结局指标
主要结局
-
efficacy rate
次要结局
- Appearance of abdominal symptoms
- Decrease in size of hepatic lesion in abdominal CT
- Decrease in size of Parasite clearance time
- Appearance of hepatic dysfunction
- Appearance of skin eruption
研究者
相似试验
尚未招募
不适用
Clinical study on the treatment of intractable facial paralysis by special acupuncture and moxibustion by Professor Yang JuIntractable facial paralysisITMCTR2200006743The First Affiliated Hospital of Anhui University 0f Chinese Medicine
撤回
不适用
Descemetorhexis only* for treatment of Fuchs endothelial dystrophyFuchs endothelial dystrophy / corneal disease1001591910015957NL-OMON45640Melles Hoornvlieskliniek Rotterdam (MHR)20
已完成
不适用
Additional treatment with fibrates for patients treated with pitavastatin under ordinary medical practice for hypertriglyceridemia in JapaCombined dyslipidemiaJPRN-UMIN000001828Chu-NET60
尚未招募
不适用
Treatment concepts of Life Threatening Soft Tissue InfectioCTRI/2019/12/022525A
尚未招募
不适用
Role of Nidana Parivarjana And Prakriti Vighata in Shleshmaja KrimiCTRI/2020/08/027250Rishikul Campus